GlassScriptPhysician profile
Dale E Solomon
NPI 1134185242
$1,219.42
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $303 · 2021: $155 · 2022: $113 · 2023: $175 · 2024: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $375.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $142.19 | 2019-2024 | |
| Pfizer INC. | $116.50 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $110.50 | 2020-2022 | |
| Glaxosmithkline, LLC. | $98.33 | 2019-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| E.R. Squibb & Sons, L.L.C. | $95.78 | 2019-2023 | Camzyos |
| Inogen, INC. | $88.89 | 2022-2024 | Inogen At Home Stationary Concentrator, Inogen One G5 Oxygen Concentrator - Bluetooth |
| Esperion Therapeutics, INC. | $88.70 | 2020-2021 | |
| Amarin Pharma, INC. | $75.39 | 2019-2021 | |
| Amgen INC. | $70.28 | 2019-2022 | |
| Lilly USA, LLC | $66.30 | 2021-2024 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.28 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $40.92 | 2022-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $36.41 | 2019-2020 | |
| Circassia INC. | $28.53 | 2019 | |
| Eisai INC. | $24.06 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.37 | 2024 | Xifaxan |
| Exact Sciences Corporation | $19.52 | 2023 | Cologuard Collection Kit |
| Abbvie INC. | $16.01 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.93 | 2021 | |
| Dexcom, INC. | $12.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dale Solomon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.